Page last updated: 2024-08-18

tetraethylenepentamine and Angiogenesis, Pathologic

tetraethylenepentamine has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H; Asai, T; Dewa, T; Kato, H; Koide, H; Maeda, N; Nango, M; Oku, N; Yokota, M; Yonenaga, N1
Ando, H; Asai, T; Dewa, T; Okamoto, A; Oku, N; Shimizu, K; Yokota, M1

Other Studies

2 other study(ies) available for tetraethylenepentamine and Angiogenesis, Pathologic

ArticleYear
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
    Nanomedicine : nanotechnology, biology, and medicine, 2015, Volume: 11, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Proliferation; Ethylenediamines; Liposomes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphatidylethanolamines; Phosphorylation; Polyethylene Glycols; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases

2015
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.
    The journal of gene medicine, 2013, Volume: 15, Issue:1

    Topics: Angiogenesis Inhibitors; Blotting, Western; Cells, Cultured; Ethylenediamines; Gene Expression Regulation; Gene Knockdown Techniques; Gene Transfer Techniques; Human Umbilical Vein Endothelial Cells; Humans; Integrin alpha5; Liposomes; MAP Kinase Kinase 4; MicroRNAs; Microscopy, Confocal; Neoplasms; Neovascularization, Pathologic; Receptors, Lysosphingolipid; RNA Interference; Sphingosine-1-Phosphate Receptors

2013